WO2010009382A3 - Analyte measurement and management device and associated methods - Google Patents

Analyte measurement and management device and associated methods Download PDF

Info

Publication number
WO2010009382A3
WO2010009382A3 PCT/US2009/050971 US2009050971W WO2010009382A3 WO 2010009382 A3 WO2010009382 A3 WO 2010009382A3 US 2009050971 W US2009050971 W US 2009050971W WO 2010009382 A3 WO2010009382 A3 WO 2010009382A3
Authority
WO
WIPO (PCT)
Prior art keywords
therapeutic agent
user
wireless module
delivery device
analyte measurement
Prior art date
Application number
PCT/US2009/050971
Other languages
French (fr)
Other versions
WO2010009382A2 (en
Inventor
Zara Sieh
David Horwitz
David Price
Peter Krulevitch
Donna Savage
Robert Shartle
Original Assignee
Lifescan, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lifescan, Inc. filed Critical Lifescan, Inc.
Priority to JP2011518932A priority Critical patent/JP2012507309A/en
Priority to BRPI0916001A priority patent/BRPI0916001A2/en
Priority to CA2731031A priority patent/CA2731031A1/en
Priority to EP09798798A priority patent/EP2315549A2/en
Priority to CN2009801325402A priority patent/CN102548467A/en
Publication of WO2010009382A2 publication Critical patent/WO2010009382A2/en
Publication of WO2010009382A3 publication Critical patent/WO2010009382A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Surgery (AREA)
  • Optics & Photonics (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Various embodiments of a diabetes management system are provided. One exemplary system may include an analyte measurement device and a therapeutic agent delivery device. The measurement device includes a measurement unit, display, and first wireless module. The therapeutic agent delivery device has a delivery device housing, delivery mechanism disposed in the housing that delivers a dosage of the agent to the user upon actuation by the user or health care provider, and a second wireless module. The second module, automatically, without prompting from a user or any active input or action by the user, transmits a signal to the first wireless module indicative of: (a) type of therapeutic agent delivered; and (b) amount of therapeutic agent delivered to the user; or (c) type of therapeutic agent device from which the therapeutic agent was administered. Also described are diabetes management devices and methods.
PCT/US2009/050971 2008-07-18 2009-07-17 Analyte measurement and management device and associated methods WO2010009382A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2011518932A JP2012507309A (en) 2008-07-18 2009-07-17 Analyte measurement and management apparatus and related methods
BRPI0916001A BRPI0916001A2 (en) 2008-07-18 2009-07-17 analyte measurement and management device and associated methods
CA2731031A CA2731031A1 (en) 2008-07-18 2009-07-17 Analyte measurement and management device and associated methods
EP09798798A EP2315549A2 (en) 2008-07-18 2009-07-17 Analyte measurement and management device and associated methods
CN2009801325402A CN102548467A (en) 2008-07-18 2009-07-17 Analyte measurement and management device and associated methods

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8210608P 2008-07-18 2008-07-18
US61/082,106 2008-07-18

Publications (2)

Publication Number Publication Date
WO2010009382A2 WO2010009382A2 (en) 2010-01-21
WO2010009382A3 true WO2010009382A3 (en) 2012-08-02

Family

ID=41530902

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/050971 WO2010009382A2 (en) 2008-07-18 2009-07-17 Analyte measurement and management device and associated methods

Country Status (7)

Country Link
US (1) US20100016700A1 (en)
EP (1) EP2315549A2 (en)
JP (1) JP2012507309A (en)
CN (1) CN102548467A (en)
BR (1) BRPI0916001A2 (en)
CA (1) CA2731031A1 (en)
WO (1) WO2010009382A2 (en)

Families Citing this family (115)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US7025774B2 (en) 2001-06-12 2006-04-11 Pelikan Technologies, Inc. Tissue penetration device
AU2002348683A1 (en) 2001-06-12 2002-12-23 Pelikan Technologies, Inc. Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
AU2002315180A1 (en) 2001-06-12 2002-12-23 Pelikan Technologies, Inc. Electric lancet actuator
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
DE60234598D1 (en) 2001-06-12 2010-01-14 Pelikan Technologies Inc SELF-OPTIMIZING LANZET DEVICE WITH ADAPTANT FOR TEMPORAL FLUCTUATIONS OF SKIN PROPERTIES
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9795334B2 (en) * 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7232451B2 (en) 2002-04-19 2007-06-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US7491178B2 (en) 2002-04-19 2009-02-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7229458B2 (en) 2002-04-19 2007-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7909778B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US7175642B2 (en) 2002-04-19 2007-02-13 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US8360992B2 (en) 2002-04-19 2013-01-29 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US7226461B2 (en) 2002-04-19 2007-06-05 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
US7331931B2 (en) 2002-04-19 2008-02-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8372016B2 (en) 2002-04-19 2013-02-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling and analyte sensing
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7297122B2 (en) 2002-04-19 2007-11-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
EP2238892A3 (en) 2003-05-30 2011-02-09 Pelikan Technologies Inc. Apparatus for body fluid sampling
WO2004107964A2 (en) 2003-06-06 2004-12-16 Pelikan Technologies, Inc. Blood harvesting device with electronic control
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
US8282576B2 (en) 2003-09-29 2012-10-09 Sanofi-Aventis Deutschland Gmbh Method and apparatus for an improved sample capture device
EP1680014A4 (en) 2003-10-14 2009-01-21 Pelikan Technologies Inc Method and apparatus for a variable user interface
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
WO2005065414A2 (en) 2003-12-31 2005-07-21 Pelikan Technologies, Inc. Method and apparatus for improving fluidic flow and sample capture
WO2006011062A2 (en) 2004-05-20 2006-02-02 Albatros Technologies Gmbh & Co. Kg Printable hydrogel for biosensors
US9775553B2 (en) 2004-06-03 2017-10-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
EP1765194A4 (en) 2004-06-03 2010-09-29 Pelikan Technologies Inc Method and apparatus for a fluid sampling device
WO2006072004A2 (en) * 2004-12-30 2006-07-06 Pelikan Technologies, Inc. Method and apparatus for analyte measurement test time
US8652831B2 (en) 2004-12-30 2014-02-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte measurement test time
US10624577B2 (en) 2008-04-04 2020-04-21 Hygieia, Inc. Systems, devices, and methods for alleviating glucotoxicity and restoring pancreatic beta-cell function in advanced diabetes mellitus
US9220456B2 (en) 2008-04-04 2015-12-29 Hygieia, Inc. Systems, methods and devices for achieving glycemic balance
CN103400028B (en) * 2008-04-04 2017-04-12 海吉雅有限公司 Device for optimizing patient's insulin dosage regimen
WO2009126900A1 (en) 2008-04-11 2009-10-15 Pelikan Technologies, Inc. Method and apparatus for analyte detecting device
US20100095229A1 (en) * 2008-09-18 2010-04-15 Abbott Diabetes Care, Inc. Graphical user interface for glucose monitoring system
WO2010056718A2 (en) 2008-11-11 2010-05-20 Hygieia, Inc. Apparatus and system for diabetes management
KR101285520B1 (en) 2008-12-23 2013-07-17 에프. 호프만-라 로슈 아게 Structured testing method for diagnostic or therapy support of a patient with a chronic disease and devices thereof
US10456036B2 (en) 2008-12-23 2019-10-29 Roche Diabetes Care, Inc. Structured tailoring
US10437962B2 (en) 2008-12-23 2019-10-08 Roche Diabetes Care Inc Status reporting of a structured collection procedure
US9117015B2 (en) 2008-12-23 2015-08-25 Roche Diagnostics Operations, Inc. Management method and system for implementation, execution, data collection, and data analysis of a structured collection procedure which runs on a collection device
US20120011125A1 (en) 2008-12-23 2012-01-12 Roche Diagnostics Operations, Inc. Management method and system for implementation, execution, data collection, and data analysis of a structured collection procedure which runs on a collection device
US9918635B2 (en) 2008-12-23 2018-03-20 Roche Diabetes Care, Inc. Systems and methods for optimizing insulin dosage
US8849458B2 (en) 2008-12-23 2014-09-30 Roche Diagnostics Operations, Inc. Collection device with selective display of test results, method and computer program product thereof
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
JP5871797B2 (en) * 2009-06-30 2016-03-01 ライフスキャン・スコットランド・リミテッド Diabetes management system and method
CA2766944C (en) * 2009-06-30 2019-10-29 Lifescan, Inc. Analyte testing methods and device for calculating basal insulin therapy
CN102483775A (en) * 2009-06-30 2012-05-30 生命扫描有限公司 Analyte testing method and system
CA2957595C (en) * 2009-09-29 2020-06-02 Lifescan Scotland Limited Analyte testing method and device for diabetes management
WO2011106030A1 (en) * 2010-02-25 2011-09-01 Lifescan Scotland Limited Analyte testing method and system with safety warnings for insulin dosing
US9563743B2 (en) * 2010-02-25 2017-02-07 Lifescan Scotland Limited Analyte testing method and system with high and low blood glucose trends notification
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8532933B2 (en) 2010-06-18 2013-09-10 Roche Diagnostics Operations, Inc. Insulin optimization systems and testing methods with adjusted exit criterion accounting for system noise associated with biomarkers
JP2012032206A (en) * 2010-07-29 2012-02-16 National Institute Of Advanced Industrial & Technology Electrochemical analysis device
US8206340B2 (en) * 2010-08-18 2012-06-26 Thuban, Inc. Integrated glucose monitor and insulin injection pen with automatic emergency notification
US8868794B2 (en) 2010-12-27 2014-10-21 Medtronic, Inc. Application limitations for a medical communication module and host device
US20120173151A1 (en) 2010-12-29 2012-07-05 Roche Diagnostics Operations, Inc. Methods of assessing diabetes treatment protocols based on protocol complexity levels and patient proficiency levels
CH704393B1 (en) * 2011-01-28 2020-04-30 D Van Gelder Max Device for the control of data relevant to diabetes.
US9619625B2 (en) 2011-03-30 2017-04-11 Novo Nordisk A/S System for optimizing a patient's drug dosage regimen over time
WO2012152628A1 (en) 2011-05-06 2012-11-15 Novo Nordisk A/S System for optimizing a drug dosage regimen over time
US10448869B2 (en) 2011-05-13 2019-10-22 Roche Diabetes Care, Inc. User-defined structured testing for use in diabetes care
US8766803B2 (en) 2011-05-13 2014-07-01 Roche Diagnostics Operations, Inc. Dynamic data collection
US8755938B2 (en) 2011-05-13 2014-06-17 Roche Diagnostics Operations, Inc. Systems and methods for handling unacceptable values in structured collection protocols
US20130085349A1 (en) 2011-06-21 2013-04-04 Yofimeter, Llc Analyte testing devices
EP2798546B1 (en) * 2011-09-13 2020-12-23 Novo Nordisk A/S Adaptive system for optimizing a drug dosage regimen over time
WO2013053695A1 (en) 2011-10-11 2013-04-18 Novo Nordisk A/S Dual purpose advisory device
US9259190B2 (en) 2011-12-29 2016-02-16 Roche Diabetes Care, Inc. Reminder management for manual entry diabetes application
US8886619B2 (en) 2011-12-29 2014-11-11 Roche Diagnostics Operations, Inc. Structured test adherence management for manual data entry systems
CN103190914A (en) * 2012-01-04 2013-07-10 胡吉 Data wireless transmission device for glucometer
WO2014008288A1 (en) * 2012-07-03 2014-01-09 Edwards Lifesciences Corporation Therapeutic agent delivery based on stored patient analyte values
US10318915B2 (en) 2012-09-26 2019-06-11 Thuban, Inc. Healthcare system for recording and monitoring transactions of system participants
US9357961B2 (en) 2013-02-22 2016-06-07 Thuban, Inc. Device for enabling patient self testing and treatment self- administration and system using the device for managing the patient's health care
US20140275903A1 (en) * 2013-03-14 2014-09-18 Lifescan Scotland Limited System and method for quick-access physiological measurement history
US9377485B2 (en) 2013-03-15 2016-06-28 Fluke Corporation Handheld measurement system with selectable options
US10453566B2 (en) 2013-04-26 2019-10-22 Roche Diabetes Care, Inc. Method for reconciling medical data captured on one device with a structured test administered on another device
US20140379360A1 (en) * 2013-06-25 2014-12-25 Lifescan, Inc. Low glucose treatment for people with diabetes
PT107092B (en) * 2013-07-31 2015-11-04 Têxteis Penedo S A COMPOSITE MATERIAL, PROCESS OF OBTAINMENT AND ITS APPLICATIONS
US11520890B2 (en) * 2013-10-25 2022-12-06 Ascensia Diabetes Care Holdings Ag Hardware key system for device protection
US9233204B2 (en) 2014-01-31 2016-01-12 Aseko, Inc. Insulin management
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
GB201407896D0 (en) * 2014-05-05 2014-06-18 Joanneum Res Forschungsgmbh Insulin dosage proposal system
DE202015010002U1 (en) * 2014-05-21 2022-12-12 Abbott Diabetes Care, Inc. Management of multiple devices within an analyte monitoring environment
US11035818B2 (en) * 2014-08-15 2021-06-15 Roche Diabetes Care, Inc. Blood glucose meter with low cost user interface having programmed graphic indicators
WO2016040345A1 (en) * 2014-09-10 2016-03-17 Bayer Healthcare Llc Smart logging for management of health-related issues
US10704944B2 (en) 2014-09-14 2020-07-07 Becton, Dickinson And Company System and method for capturing dose information
US10971260B2 (en) 2014-09-14 2021-04-06 Becton, Dickinson And Company System and method for capturing dose information
EP3050023B1 (en) 2014-10-27 2021-08-25 Aseko, Inc. Subcutaneous outpatient management
US11081226B2 (en) 2014-10-27 2021-08-03 Aseko, Inc. Method and controller for administering recommended insulin dosages to a patient
CA2993275C (en) 2015-08-20 2022-06-21 Aseko, Inc. Diabetes management therapy advisor
EP3838138A3 (en) * 2015-08-26 2021-09-15 ResMed Sensor Technologies Limited Systems and methods for monitoring and management of chronic disease
US10980941B2 (en) 2016-03-31 2021-04-20 Dexcom, Inc. Methods for providing an alert or an alarm to a user of a mobile communications device
EP3519011A4 (en) * 2016-09-27 2020-05-20 Bigfoot Biomedical, Inc. Medicine injection and disease management systems, devices, and methods
EP3500161A4 (en) 2016-12-12 2020-01-08 Bigfoot Biomedical, Inc. Alarms and alerts for medication delivery devices and related systems and methods
CN107158522A (en) * 2017-05-31 2017-09-15 北京糖护科技有限公司 A kind of insulin syringe intelligent device
USD839294S1 (en) 2017-06-16 2019-01-29 Bigfoot Biomedical, Inc. Display screen with graphical user interface for closed-loop medication delivery
CN111263650B (en) * 2017-10-31 2022-06-21 诺和诺德股份有限公司 Controlling medical devices using wireless communication
US11967407B2 (en) * 2018-07-26 2024-04-23 Sanofi Method of adjusting medication doses
WO2021170641A1 (en) 2020-02-25 2021-09-02 Novo Nordisk A/S Add-on dose logging device with dose guidance functionality
US20230256166A1 (en) * 2022-02-16 2023-08-17 Modular Medical, Inc. Portable infusion pump with remote activator

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925021A (en) * 1994-03-09 1999-07-20 Visionary Medical Products, Inc. Medication delivery device with a microprocessor and characteristic monitor
WO2003047426A1 (en) * 2001-12-03 2003-06-12 Eli Lilly And Company Medication delivery device having communication capability with glucose monitor
US20050038674A1 (en) * 2003-04-15 2005-02-17 Braig James R. System and method for managing a chronic medical condition
US20050050330A1 (en) * 2003-08-27 2005-03-03 Leedor Agam Security token
US20060010098A1 (en) * 2004-06-04 2006-01-12 Goodnow Timothy T Diabetes care host-client architecture and data management system
US20070060800A1 (en) * 2001-06-29 2007-03-15 Darrel Drinan Gateway platform for biological monitoring and delivery of therapeutic compounds

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US654672A (en) * 1899-09-05 1900-07-31 Harry T Rich Bicycle-lock.
US4731726A (en) * 1986-05-19 1988-03-15 Healthware Corporation Patient-operated glucose monitor and diabetes management system
US5307263A (en) * 1992-11-17 1994-04-26 Raya Systems, Inc. Modular microprocessor-based health monitoring system
US5665065A (en) * 1995-05-26 1997-09-09 Minimed Inc. Medication infusion device with blood glucose data input
US6270455B1 (en) * 1997-03-28 2001-08-07 Health Hero Network, Inc. Networked system for interactive communications and remote monitoring of drug delivery
KR100620257B1 (en) * 1998-11-30 2006-09-13 노보 노르디스크 에이/에스 A medical system and a method of controlling the system for use by a patient for medical self treatment
US6192891B1 (en) * 1999-04-26 2001-02-27 Becton Dickinson And Company Integrated system including medication delivery pen, blood monitoring device, and lancer
US6804656B1 (en) * 1999-06-23 2004-10-12 Visicu, Inc. System and method for providing continuous, expert network critical care services from a remote location(s)
US6544212B2 (en) * 2001-07-31 2003-04-08 Roche Diagnostics Corporation Diabetes management system
JP2004538078A (en) * 2001-08-20 2004-12-24 インバネス・メディカル・リミテッド Wireless diabetes management device and method of using wireless diabetes management device
US20030040821A1 (en) * 2001-08-24 2003-02-27 Christopher Case System and method for portable personal diabetic management
US20030114885A1 (en) * 2001-10-02 2003-06-19 Nova Richard C. System and device for implementing an integrated medical device component package
US20030212379A1 (en) * 2002-02-26 2003-11-13 Bylund Adam David Systems and methods for remotely controlling medication infusion and analyte monitoring
US6852104B2 (en) * 2002-02-28 2005-02-08 Smiths Medical Md, Inc. Programmable insulin pump
JP2004000555A (en) * 2002-04-25 2004-01-08 Matsushita Electric Ind Co Ltd Dosage determination support device, syringe, and health care support system
US7278983B2 (en) * 2002-07-24 2007-10-09 Medtronic Minimed, Inc. Physiological monitoring device for controlling a medication infusion device
EP1575656B1 (en) * 2002-10-11 2009-06-17 Becton, Dickinson and Company Insulin delivery system with sensor
US8016798B2 (en) * 2003-02-24 2011-09-13 Integrated Sensing Systems, Inc. Fluid delivery system and sensing unit therefor
WO2004084820A2 (en) * 2003-03-19 2004-10-07 Harry Hebblewhite Method and system for determining insulin dosing schedules and carbohydrate-to-insulin ratios in diabetic patients
AU2004232289A1 (en) * 2003-04-18 2004-11-04 Insulet Corporation User interface for infusion pump remote controller and method of using the same
US7591801B2 (en) * 2004-02-26 2009-09-22 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
WO2005046559A2 (en) * 2003-11-06 2005-05-26 Lifescan, Inc. Drug delivery pen with event notification means
US8532730B2 (en) * 2006-10-04 2013-09-10 Dexcom, Inc. Analyte sensor
US20050137573A1 (en) * 2003-12-19 2005-06-23 Animas Corporation System, method, and communication hub for controlling external infusion device
WO2005106017A2 (en) * 2004-04-21 2005-11-10 University Of Virginia Patent Foundation Method, system and computer program product for evaluating the accuracy of blood glucose monitoring sensors/devices
CN101027675A (en) * 2004-09-23 2007-08-29 诺和诺德公司 Remote commander to be used with a drug delivery device
US20060089540A1 (en) * 2004-10-27 2006-04-27 Alan Meissner Device for diabetes management
US20060173417A1 (en) * 2005-01-10 2006-08-03 Richard Rosen Combination insulin pen and transmission device
EP2162168B1 (en) * 2005-09-26 2018-11-07 Bigfoot Biomedical, Inc. Modular infusion pump having two different energy sources
EP1955240B8 (en) * 2005-11-08 2016-03-30 Bigfoot Biomedical, Inc. Method for manual and autonomous control of an infusion pump
US7981034B2 (en) * 2006-02-28 2011-07-19 Abbott Diabetes Care Inc. Smart messages and alerts for an infusion delivery and management system
US7824333B2 (en) * 2006-03-31 2010-11-02 Lifescan, Inc. Diabetes management methods and systems
US20070255125A1 (en) * 2006-04-28 2007-11-01 Moberg Sheldon B Monitor devices for networked fluid infusion systems

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925021A (en) * 1994-03-09 1999-07-20 Visionary Medical Products, Inc. Medication delivery device with a microprocessor and characteristic monitor
US20070060800A1 (en) * 2001-06-29 2007-03-15 Darrel Drinan Gateway platform for biological monitoring and delivery of therapeutic compounds
WO2003047426A1 (en) * 2001-12-03 2003-06-12 Eli Lilly And Company Medication delivery device having communication capability with glucose monitor
US20050038674A1 (en) * 2003-04-15 2005-02-17 Braig James R. System and method for managing a chronic medical condition
US20050050330A1 (en) * 2003-08-27 2005-03-03 Leedor Agam Security token
US20060010098A1 (en) * 2004-06-04 2006-01-12 Goodnow Timothy T Diabetes care host-client architecture and data management system

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
EDELMAN ET AL.: "A Practical Approach for Implementation of a Basal-Prandial Insulin Therapy Regimen in Patients with Type 2 Diabetes.", OSTEOPATH MED PRIM CARE., vol. 1, 20 April 2007 (2007-04-20), pages 9, XP021030885 *

Also Published As

Publication number Publication date
CN102548467A (en) 2012-07-04
JP2012507309A (en) 2012-03-29
BRPI0916001A2 (en) 2019-07-09
EP2315549A2 (en) 2011-05-04
CA2731031A1 (en) 2010-01-21
WO2010009382A2 (en) 2010-01-21
US20100016700A1 (en) 2010-01-21

Similar Documents

Publication Publication Date Title
WO2010009382A3 (en) Analyte measurement and management device and associated methods
WO2012056405A3 (en) Pressure sensor assembly and associated method for preventing the development of pressure injuries
WO2016007935A3 (en) Medicine administering system including injection pen and companion device
WO2009105337A3 (en) Continuous medicament sensor system for in vivo use
WO2011060923A3 (en) Diabetes health management systems
WO2008039728A3 (en) Systems and methods for improving medication adherence
AU2016204377A1 (en) User interface improvements for medical devices
NO20072130L (en) Dose display mechanism for drug delivery device
WO2008157701A3 (en) Personal virtual assistant
HK1133217A1 (en) Combined drug delivery and analyte sensor apparatus
MX2011011662A (en) Model-based infusion site monitor.
WO2008128740A8 (en) Titration of tapentadol
WO2006128536A3 (en) Medical treatment system comprising a device for providing patient-related data
AU2003215064A1 (en) Autonomous, ambulatory analyte monitor or drug delivery device
ATE446713T1 (en) EXTERNAL DRAIN SENSOR SYSTEM
WO2008027490A3 (en) Patient-interactive healthcare management
WO2009079589A3 (en) Integrated intra-dermal delivery, diagnostic and communication system
WO2008011389A3 (en) Medical systems and methods of use
WO2007108987A3 (en) Infusion device pump
EP1913892A3 (en) Method and system to monitor hand hygiene compliance
WO2009045785A3 (en) Disposable infusion device with tactile dosage volume indicator
WO2008079979A3 (en) Implantable cardiac stimulus devices and methods with input recharge circuitry
WO2007081947A3 (en) Drug storage and dispensing devices and systems comprising the same
BRPI0518855A2 (en) medicine for hygienic application to the ear
BR112012020270A2 (en) system and method for administering medicines based on urine values.

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200980132540.2

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09798798

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2731031

Country of ref document: CA

Ref document number: 2011518932

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 543/KOLNP/2011

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2009798798

Country of ref document: EP

REG Reference to national code

Ref country code: BR

Ref legal event code: B01E

Ref document number: PI0916001

Country of ref document: BR

Free format text: COMPROVE O DIREITO DE REIVINDICAR A PRIORIDADE 18/07/2008 US 61/082,106 APRESENTANDODOCUMENTO DE CESSAO CONTENDO OS DADOS DESTA PRIORIDADE, CONFORME A RESOLUCAOINPI/PR NO 179 DE 21/02/2017 NO ART 2O 1O, UMA VEZ QUE OS DOCUMENTOS DE CESSAOAPRESENTADOS NA PETICAO 020110005854 NAO POSSUI O NUMERO DESSA PRIORIDADE

ENP Entry into the national phase

Ref document number: PI0916001

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20110118